Publication | Open Access
Interleukin-6 is a potential therapeutic target in interleukin-6 dependent, estrogen receptor-α-positive breast cancer
27
Citations
54
References
2016
Year
Given the established role for IL-6 in ERα-positive breast cancer, these data demonstrate the potential for anti-IL-6 therapeutics in breast cancer.
| Year | Citations | |
|---|---|---|
Page 1
Page 1